Skip to main content
Log in

Serrated Polyps: Clinical Implications and Future Directions

  • Large Intestine (B Cash, Section Editor)
  • Published:
Current Gastroenterology Reports Aims and scope Submit manuscript

Abstract

Serrated polyps were once thought to have no clinical implications with regards to the development of colorectal cancer (CRC). Over the past several years, published data have enabled clinicians to develop a better understanding of these lesions. The serrated pathway associated with these lesions involves an epigenetic mechanism characterized by abnormal hypermethylation of CpG islands located in the promoter regions of tumor suppressor genes. It is often associated with BRAF mutations and may account for 15–35 % of all CRC. This pathway may also play a major role in proximal neoplasia and missed cancer. There are three distinct subtypes of serrated neoplasia; hyperplastic (70 % of all serrated polyps), sessile serrated adenoma/polyp (SSA/P) (25 %) and traditional serrated adenoma (<2 %). The last two forms are considered to be precursors for CRC. SSA/P are associated with synchronous CRC especially if the polyps are large (≥1 cm), multiple, or if they are in the proximal colon. Lesions containing serrated neoplasia are usually flat or sessile, may be large, and occasionally have a mucous cap. Serrated lesions provide many challenges for the clinician and may be difficult to detect and completely remove. Furthermore, pathologists may misclassify SSA/P as HP. For the first time, the Multi-Society Task Force guidelines for colorectal polyp surveillance have included the management of serrated lesions in their published recommendations. In addition, an expert panel has also recently issued recommendations regarding serrated neoplasia. In this article, we provide the reader with a summary as well as the latest developments regarding serrated colonic lesions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, Levin TR, et al. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2012;143(3):844–57.

    Article  PubMed  Google Scholar 

  2. • Rex DK, Ahnen DJ, Baron JA, Batts KP, Burke CA, Burt RW, et al. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol. 2012;107(9):1315–29. This article is important because it provides the first set of recommendations for surveillance of patients with serrated polyps. The recommendations that are provided aid the clinician by stratifying serrated lesions by anatomic location and size rather than depending on histology which has poor inter observer reliability.

    Article  PubMed  Google Scholar 

  3. Leggett B, Whitehall V. Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology. 2010;138(6):2088–100.

    Article  PubMed  CAS  Google Scholar 

  4. Snover DC, Ahnen DJ, Burt RW, Odze RD. Serrated lesions of the colon and rectum and serrated polyposis. Tumours of the colon and rectum; 2010.

  5. Snover DC, Jass JR, Fenoglio-Preiser C, Batts KP. Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept. Am J Clin Pathol. 2005;124(3):380–91.

    Article  PubMed  Google Scholar 

  6. Ogino S, Nosho K, Kirkner GJ, Kawasaki T, Meyerhardt JA, Loda M, et al. CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut. 2009;58(1):90–6.

    Article  PubMed  Google Scholar 

  7. • Anderson JC, Rangasamy P, Rustagi T, Myers M, Sanders M, Vaziri H, et al. Risk factors for sessile serrated adenomas. J Clin Gastroenterol. 2011;45(8):694–9. This is the first article to examine sessile serrated polyps versus combining all serrated polyps which are a heterogeneous group. In addition to smoking, they identify obesity and diabetes as potential risk factors.

    Article  PubMed  Google Scholar 

  8. Arain MA, Sawhney M, Sheikh S, Anway R, Thyagarajan B, Bond JH, et al. CIMP status of interval colon cancers: another piece to the puzzle. Am J Gastroenterol. 2010;105(5):1189–95.

    Article  PubMed  Google Scholar 

  9. Bressler B, Paszat LF, Chen Z, Rothwell DM, Vinden C, Rabeneck L. Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis. Gastroenterology. 2007;132(1):96–102.

    Article  PubMed  Google Scholar 

  10. Kahi CJ, Hewett DG, Norton DL, Eckert GJ, Rex DK. Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy. Clin Gastroenterol Hepatol. 2011;9(1):42–6.

    Article  PubMed  Google Scholar 

  11. Clark JC, Collan Y, Eide TJ, Esteve J, Ewen S, Gibbs NM, et al. Prevalence of polyps in an autopsy series from areas with varying incidence of large-bowel cancer. Int J Cancer. 1985;36(2):179–86.

    Article  PubMed  CAS  Google Scholar 

  12. Vatn MH, Stalsberg H. The prevalence of polyps of the large intestine in Oslo: an autopsy study. Cancer. 1982;49(4):819–25.

    Article  PubMed  CAS  Google Scholar 

  13. Johannsen LG, Momsen O, Jacobsen NO. Polyps of the large intestine in Aarhus, Denmark. An autopsy study. Scand J Gastroenterol. 1989;24(7):799–806.

    Article  PubMed  CAS  Google Scholar 

  14. Hetzel JT, Huang CS, Coukos JA, Omstead K, Cerda SR, Yang S, et al. Variation in the detection of serrated polyps in an average risk colorectal cancer screening cohort. Am J Gastroenterol. 2010;105(12):2656–64.

    Article  PubMed  Google Scholar 

  15. Spring KJ, Zhao ZZ, Karamatic R, Walsh MD, Whitehall VL, Pike T, et al. High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology. 2006;131(5):1400–7.

    Article  PubMed  CAS  Google Scholar 

  16. Lash RH, Genta RM, Schuler CM. Sessile serrated adenomas: prevalence of dysplasia and carcinoma in 2139 patients. J Clin Pathol. 2010;63(8):681–6.

    Article  PubMed  Google Scholar 

  17. Kahi CJ, Anderson JC, Waxman I, Kessler WR, Imperiale TF, Li X, et al. High-definition chromocolonoscopy vs. high-definition white light colonoscopy for average-risk colorectal cancer screening. Am J Gastroenterol. 2010;105(6):1301–7.

    Article  PubMed  Google Scholar 

  18. Snover DC. Serrated polyps of the large intestine. Semin Diagn Pathol. 2005;22(4):301–8.

    Article  PubMed  Google Scholar 

  19. Snover DC. Update on the serrated pathway to colorectal carcinoma. Hum Pathol. 2011;42(1):1–10.

    Article  PubMed  Google Scholar 

  20. Anderson JC, Pleau DC, Rajan TV, Protiva P, Swede H, Brenner B, et al. Increased frequency of serrated aberrant crypt foci among smokers. Am J Gastroenterol. 2010;105(7):1648–54.

    Article  PubMed  Google Scholar 

  21. • Burnett-Hartman AN, Newcomb PA, Phipps AI, Passarelli MN, Grady WM, Upton MP, et al. Colorectal endoscopy, advanced adenomas, and sessile serrated polyps: implications for proximal colon cancer. Am J Gastroenterol. 2012;107(8):1213–9. This study demonstrated the chasm between advanced adenoma and serrated polyp detection.

    Article  PubMed  Google Scholar 

  22. Hiraoka S, Kato J, Fujiki S, Kaji E, Morikawa T, Murakami T, et al. The presence of large serrated polyps increases risk for colorectal cancer. Gastroenterology. 2010;139(5):1503–10. 10 e1-3.

    Article  PubMed  Google Scholar 

  23. Li D, Jin C, McCulloch C, Kakar S, Berger BM, Imperiale TF, et al. Association of large serrated polyps with synchronous advanced colorectal neoplasia. Am J Gastroenterol. 2009;104(3):695–702.

    Article  PubMed  Google Scholar 

  24. Schreiner MA, Weiss DG, Lieberman DA. Proximal and large hyperplastic and nondysplastic serrated polyps detected by colonoscopy are associated with neoplasia. Gastroenterology. 2010;139(5):1497–502.

    Article  PubMed  Google Scholar 

  25. Anderson JC, Swede H, Rustagi T, Protiva P, Pleau D, Brenner BM, et al. Aberrant crypt foci as predictors of colorectal neoplasia on repeat colonoscopy. Cancer Causes Control. 2012;23(2):355–61.

    Article  PubMed  Google Scholar 

  26. Lu FI, van Niekerk de W, Owen D, Tha SP, Turbin DA, Webber DL. Longitudinal outcome study of sessile serrated adenomas of the colorectum: an increased risk for subsequent right-sided colorectal carcinoma. Am J Surg Pathol. 2010;34(7):927–34.

    Article  PubMed  Google Scholar 

  27. Anderson JC, Pollack BJ. Predicting of hyperplastic histology by endoscopic features. Gastrointest Endosc. 2000;52(1):149–50.

    PubMed  CAS  Google Scholar 

  28. Rex DK, Rahmani EY. New endoscopic finding associated with hyperplastic polyps. Gastrointest Endosc. 1999;50(5):704–6.

    Article  PubMed  CAS  Google Scholar 

  29. Singh H, Bay D, Ip S, Bernstein CN, Nugent Z, Gheorghe R, et al. Pathological reassessment of hyperplastic colon polyps in a city-wide pathology practice: implications for polyp surveillance recommendations. Gastrointest Endosc. 2012;76(5):1003–8.

    Article  PubMed  Google Scholar 

  30. Anderson JC, Robertson DJ. Serrated polyps misclassified: the value of looking back and the impact of looking forward. Gastroenterology. 2013.

  31. Rajagopalan H, Bardelli A, Lengauer C, Kinzler KW, Vogelstein B, Velculescu VE. Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature. 2002;418(6901):934.

    Article  PubMed  CAS  Google Scholar 

  32. Sugai T, Habano W, Jiao YF, Tsukahara M, Takeda Y, Otsuka K, et al. Analysis of molecular alterations in left- and right-sided colorectal carcinomas reveals distinct pathways of carcinogenesis: proposal for new molecular profile of colorectal carcinomas. J Mol Diagn. 2006;8(2):193–201.

    Article  PubMed  CAS  Google Scholar 

  33. Heald B, Plesec T, Liu X, Pai R, Patil D, Moline J, et al. Implementation of universal microsatellite instability and immunohistochemistry screening for diagnosing lynch syndrome in a large academic medical center. J Clin Oncol. 2013;31(10):1336–40.

    Article  PubMed  Google Scholar 

  34. Ogino S, Stampfer M. Lifestyle factors and microsatellite instability in colorectal cancer: the evolving field of molecular pathological epidemiology. J Natl Cancer Inst. 2010;102(6):365–7.

    Article  PubMed  Google Scholar 

  35. Samowitz WS, Albertsen H, Herrick J, Levin TR, Sweeney C, Murtaugh MA, et al. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology. 2005;129(3):837–45.

    Article  PubMed  CAS  Google Scholar 

  36. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A. 1999;96(15):8681–6.

    Article  PubMed  CAS  Google Scholar 

  37. Kambara T, Simms LA, Whitehall VL, Spring KJ, Wynter CV, Walsh MD, et al. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut. 2004;53(8):1137–44.

    Article  PubMed  CAS  Google Scholar 

  38. Rosenberg DW, Yang S, Pleau DC, Greenspan EJ, Stevens RG, Rajan TV, et al. Mutations in BRAF and KRAS differentially distinguish serrated versus non-serrated hyperplastic aberrant crypt foci in humans. Cancer Res. 2007;67(8):3551–4.

    Article  PubMed  CAS  Google Scholar 

  39. Kalady MF, Jarrar A, Leach B, LaGuardia L, O’Malley M, Eng C, et al. Defining phenotypes and cancer risk in hyperplastic polyposis syndrome. Dis Colon Rectum. 2011;54(2):164–70.

    Article  PubMed  Google Scholar 

  40. Boparai KS, Mathus-Vliegen EM, Koornstra JJ, Nagengast FM, van Leerdam M, van Noesel CJ, et al. Increased colorectal cancer risk during follow-up in patients with hyperplastic polyposis syndrome: a multicentre cohort study. Gut. 2010;59(8):1094–100.

    Article  PubMed  Google Scholar 

  41. Win AK, Walters RJ, Buchanan DD, Jenkins MA, Sweet K, Frankel WL, et al. Cancer risks for relatives of patients with serrated polyposis. Am J Gastroenterol. 2012;107(5):770–8.

    Article  PubMed  Google Scholar 

  42. Vemulapalli KC, Rex DK. Failure to recognize serrated polyposis syndrome in a cohort with large sessile colorectal polyps. Gastrointest Endosc. 2012;75(6):1206–10.

    Article  PubMed  Google Scholar 

  43. Kahi CJ, Li X, Eckert GJ, Rex DK. High colonoscopic prevalence of proximal colon serrated polyps in average-risk men and women. Gastrointest Endosc. 2012;75(3):515–20.

    Article  PubMed  Google Scholar 

  44. Liang J, Kalady MF, Appau K, Church J. Serrated polyp detection rate during screening colonoscopy. Colorectal Dis. 2012;14(11):1323–7.

    Article  PubMed  CAS  Google Scholar 

  45. Anderson JC, Butterly L, Goodrich M, C. R, Weiss J. Adenoma and Serrated Polyp Detection Rates in Screening versus Surveillance Colonoscopies: Data from the New Hampshire Colonoscopy Registry (in press). Clinical Gastroenterology and Hepatology. 2013.

  46. de Wijkerslooth TR, Stoop EM, Bossuyt PM, Tytgat KM, Dees J, Mathus-Vliegen EM, et al. Differences in proximal serrated polyp detection among endoscopists are associated with variability in withdrawal time. Gastrointest Endosc. 2013;77(4):617–23.

    Article  PubMed  Google Scholar 

  47. Kimura T, Yamamoto E, Yamano HO, Suzuki H, Kamimae S, Nojima M, et al. A novel pit pattern identifies the precursor of colorectal cancer derived from sessile serrated adenoma. Am J Gastroenterol. 2012;107(3):460–9.

    Article  PubMed  CAS  Google Scholar 

  48. Pohl H, Srivastava A, Bensen SP, Anderson P, Rothstein RI, Gordon SR, et al. Incomplete polyp resection during colonoscopy-results of the complete adenoma resection (CARE) study. Gastroenterology. 2013;144(1):74–80 e1.

    Article  PubMed  Google Scholar 

  49. Limketkai BN, Lam-Himlin D, Arnold CA, Arnold MA. The cutting edge of serrated polyps: a practical guide to approaching and managing serrated colon polyps. Gastrointest Endosc. 2013;77(3):360–75.

    Article  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Michael Tadros and Joseph C. Anderson declare that they have no conflict of interest

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Joseph C. Anderson.

Additional information

The contents of this work do not represent the views of the Department of Veterans Affairs or the United States Government

This article is part of the Topical Collection on Large Intestine

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tadros, M., Anderson, J.C. Serrated Polyps: Clinical Implications and Future Directions. Curr Gastroenterol Rep 15, 342 (2013). https://doi.org/10.1007/s11894-013-0342-4

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11894-013-0342-4

Keywords

Navigation